topotecan hydrochloride [clinicaltrials_resource:0736efe86e8795b3854aab1ed4b18cb8]
Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung Cancer [clinicaltrials:NCT00002537]Paclitaxel Plus Topotecan in Treating Patients With Solid Tumors [clinicaltrials:NCT00002587]Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma [clinicaltrials:NCT00002625]clinicaltrials:NCT00002643Topotecan in Treating Children With Refractory Leukemia [clinicaltrials:NCT00002705]Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian Cancer [clinicaltrials:NCT00002734]Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas [clinicaltrials:NCT00003745]
intervention [clinicaltrials_vocabulary:intervention]
topotecan hydrochloride [clinicaltrials_resource:0736efe86e8795b3854aab1ed4b18cb8]
Bio2RDF identifier
0736efe86e8795b3854aab1ed4b18cb8
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0736efe86e8795b3854aab1ed4b18cb8
arm group [clinicaltrials_vocabulary:arm-group]
intervention name [clinicaltrials_vocabulary:intervention-name]
topotecan hydrochloride
identifier
clinicaltrials_resource:0736efe86e8795b3854aab1ed4b18cb8
title
topotecan hydrochloride
@en
type
label
topotecan hydrochloride [clinicaltrials_resource:0736efe86e8795b3854aab1ed4b18cb8]
@en